XML 13 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 31,699 $ 39,084
Accounts receivable 6,312 3,503
Supplies inventory 3,416 3,767
Prepaid expenses and other current assets 1,405 1,442
Restricted cash 120 118
Total current assets 42,952 47,914
Property and equipment, net 10,435 10,314
Finite-lived intangible assets, net 14,400 15,200
Goodwill 1,057 1,057
Restricted cash 603 603
Other assets 203 159
Total assets 69,650 75,247
Current liabilities:    
Accounts payable 3,081 5,085
Accrued liabilities 7,189 8,689
Deferred Genzyme co-promotion fee 0 948
Total current liabilities 10,270 14,722
Long-term debt 24,891 4,990
Deferred rent, net of current portion 4,484 4,283
Total liabilities 39,645 23,995
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of September 30, 2016 and December 31, 2015 0 0
Common stock, $0.001 par value; 125,000,000 shares authorized, 27,940,161 and 27,685,291 shares issued and outstanding as of September 30, 2016 and December 31, 2015, respectively 28 28
Additional paid-in capital 205,658 199,950
Accumulated deficit (175,681) (148,726)
Total stockholders’ equity 30,005 51,252
Total liabilities and stockholders’ equity $ 69,650 $ 75,247